News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
346,895 Results
Type
Article (21534)
Company Profile (150)
Press Release (325211)
Section
Business (109525)
Career Advice (884)
Deals (19032)
Drug Delivery (91)
Drug Development (53463)
Employer Resources (84)
FDA (8106)
Job Trends (8178)
News (193617)
Policy (18201)
Tag
Academia (924)
Alliances (29097)
Alzheimer's disease (635)
Approvals (8066)
Artificial intelligence (77)
Bankruptcy (171)
Best Places to Work (5929)
Biosimilars (66)
Biotechnology (70)
Cancer (503)
Cardiovascular disease (53)
Career advice (720)
Cell therapy (86)
Clinical research (43610)
Collaboration (189)
Compensation (65)
COVID-19 (1178)
Cystic fibrosis (56)
Data (522)
Diabetes (96)
Diagnostics (1875)
Drug pricing (90)
Earnings (38973)
Employer resources (77)
Events (50829)
Executive appointments (173)
FDA (8346)
Funding (141)
Gene therapy (89)
GLP-1 (478)
Government (1987)
Healthcare (6824)
Infectious disease (1224)
Inflammatory bowel disease (72)
Interviews (119)
IPO (7625)
Job creations (2463)
Job search strategy (660)
Layoffs (254)
Legal (4201)
Lung cancer (94)
Manufacturing (112)
Medical device (2185)
Medtech (2188)
Mergers & acquisitions (11422)
Metabolic disorders (316)
Neuroscience (796)
NextGen Class of 2024 (2721)
Non-profit (1998)
Northern California (616)
Obesity (201)
Opinion (179)
Patents (69)
People (34181)
Pharmaceutical (76)
Phase I (13600)
Phase II (18552)
Phase III (14851)
Pipeline (143)
Podcasts (53)
Policy (65)
Postmarket research (1689)
Preclinical (4895)
Radiopharmaceuticals (154)
Rare diseases (138)
Real estate (3261)
Regulatory (12728)
Research institute (1166)
Resumes & cover letters (141)
Southern California (563)
Startups (2118)
United States (5727)
Vaccines (224)
Weight loss (177)
Date
Today (112)
Last 7 days (434)
Last 30 days (1573)
Last 365 days (19353)
2024 (16442)
2023 (21129)
2022 (27728)
2021 (28769)
2020 (26866)
2019 (22017)
2018 (17052)
2017 (18246)
2016 (17365)
2015 (20052)
2014 (15632)
2013 (13204)
2012 (14020)
2011 (14407)
2010 (13252)
Location
Africa (437)
Arizona (52)
Asia (25166)
Australia (3335)
California (1369)
Canada (704)
China (129)
Connecticut (53)
Europe (52423)
Florida (182)
Illinois (131)
Indiana (107)
Kansas (62)
Maryland (237)
Massachusetts (1171)
Minnesota (85)
New Jersey (518)
New York (418)
North Carolina (391)
Northern California (616)
Ohio (70)
Pennsylvania (341)
South America (626)
Southern California (563)
Texas (174)
Washington State (132)
346,895 Results for "cure pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced results from two studies of RADICAVA® (edaravone) for amyotrophic lateral sclerosis (ALS) at the European Network to Cure Amyotrophic Lateral Sclerosis (ENCALS) 2024 meeting.
June 17, 2024
·
8 min read
Business
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
Cure Rare Disease, a clinical-stage nonprofit biotechnology organization, announces the addition of a Chief Advancement Officer to its leadership team and welcomes three new members to its board of directors.
June 17, 2024
·
3 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Biotech Beach
ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa
ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced the opening of the PAUSE study, the first ACTG HIV cure clinical trial to take place on the African continent.
June 13, 2024
·
5 min read
Layoffs
Athira Pharma to Lay Off 70% of Workforce
Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s disappointing results for its investigational Alzheimer’s therapy.
September 23, 2024
·
1 min read
·
Angela Gabriel
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Lone Star Bio
Texas Company’s Mission to Cure Macular Degeneration Blindness
Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium patch to cure Macular Degeneration Blindness using autologous bone marrow-derived stem cells that carry no teratoma tumor risk and requires no immunosuppression.
April 30, 2024
·
1 min read
Mergers & acquisitions
Broken Deals: 4 Pharma Assets Returned to Biotech This Year
Not all licensing deals are successful. Here,
BioSpace
examines a few noteworthy assets that Big Pharma returned in the last 12 months.
August 27, 2024
·
5 min read
·
Mollie Barnes
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
On May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma in an oral presentation at the 27th Annual Meeting of the American Society for Gene & Cell Therapy in Baltimore.
May 23, 2024
·
3 min read
Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches
Kinaxis® Inc., a global leader in end-to-end supply chain orchestration, announced that Servier, a global independent pharmaceutical group, has selected Kinaxis to help revolutionize its supply chain planning capabilities with a view to accelerating time to market for its portfolio of life-saving drugs.
May 21, 2024
·
4 min read
1 of 34,690
Next
